HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of melanoma complicated with uveitis induced by two types of BRAF/MEK inhibitors and nivolumab treatment.

AuthorsChiaki Obaru, Toshihiro Kimura, Manami Yamamura, Haruka Kuriyama, Kayo Kashiwada-Nakamura, Satoru Mizuhashi, Tomoyo Matsumura, Takahiro Watanabe, Toshihiro Inoue, Satoshi Fukushima
JournalThe Journal of dermatology (J Dermatol) Vol. 51 Issue 4 Pg. e115-e117 (Apr 2024) ISSN: 1346-8138 [Electronic] England
PMID37927219 (Publication Type: Case Reports, Letter)
Chemical References
  • Nivolumab
  • Proto-Oncogene Proteins B-raf
  • Protein Kinase Inhibitors
  • Mitogen-Activated Protein Kinase Kinases
  • BRAF protein, human
Topics
  • Humans
  • Melanoma (drug therapy)
  • Nivolumab (adverse effects)
  • Proto-Oncogene Proteins B-raf (genetics)
  • Skin Neoplasms (drug therapy)
  • Protein Kinase Inhibitors (adverse effects)
  • Uveitis (chemically induced, drug therapy)
  • Mitogen-Activated Protein Kinase Kinases
  • Antineoplastic Combined Chemotherapy Protocols (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: